By The Legacy of Henrietta Lacks
The Unintentional Architect of Modern Medicine: The Legacy of Henrietta Lacks
​In August 1920, Henrietta Lacks was born in Roanoke, Virginia. She eventually relocated with her household near Baltimore, Maryland. Living in an era marked by systemic racial segregation, Henrietta experienced significant limitations in healthcare access and equitable treatment. Despite these harsh realities, her bio-material would ultimately transform global health and preserve millions of lives.
​Her medical journey began in early 1951 when she sought care at Johns Hopkins Hospital, one of the few medical institutions in the area willing to treat Black individuals. Having recently delivered her fifth child, Henrietta noticed abnormal vaginal bleeding and felt an unusual growth in her abdomen. Medical professionals diagnosed her with a severe, fast-growing form of cervical cancer. Doctors promptly initiated treatment using radium therapy, which represented the medical standard of care during that era.
​Throughout these procedures, healthcare providers extracted samples of both normal and malignant cervical tissues from her body. They did this without explaining the procedure to her or seeking her permission. While obtaining patient consent for biological tissue research was not a required protocol during that era, the glaring ethical oversights in her treatment later catalyzed sweeping reforms regarding patient autonomy and medical ethics.
​The harvested tissue was directed to Dr. George Otto Gey, a prominent research scientist. Dr. Gey discovered that Henrietta’s cancer cells exhibited unprecedented cellular behavior. Unlike standard human cell samples, which invariably withered and perished after a few cell divisions, her biological samples multiplied continuously within laboratory conditions. This marked the creation of the world’s first immortal human cell line, designated as the HeLa line from the initial letters of her name.
​The scientific ramifications of HeLa cells have been immense. They proved essential in formulating the polio vaccine, advancing oncology research, examining viral pathogens like HIV, mapping human genomes, and perfecting in vitro fertilization. Scientists even deployed them into space to analyze cellular reactions in zero gravity. Today, decades after Henrietta passed away at age 31 on October 4, 1951, her cellular legacy remains vital to worldwide biological research.
Support our journalism
You've just read one of our articles. We work to deliver accurate, independent reporting that holds power to account and gives a voice to the stories that matter. That work depends on readers like you.
- Your contribution helps us keep our reporting free and accessible to everyone.
- We don't hide behind a paywall—we rely on the support of our community.
- Every amount, large or small, helps us produce more of the journalism you value.
Make a donation:
Donations are voluntary and non-refundable. By donating, you agree to our Terms & Conditions and Privacy Policy.
